
FDA Reports Two Deaths Linked to Illicit Retatrutide
The FDA received reports of two deaths linked to unapproved, bootleg versions of the experimental weight-loss drug retatrutide. While the agency has not verified the claims, Eli Lilly is pursuing legal action against sellers of counterfeit products, warning that contaminated or incorrect doses pose severe risks to patients.













